Dopamine: Functions, Signaling, and Association with Neurological Diseases
Open accessAbstract
The dopaminergic system plays important roles in neuromodulation, such as motor control, motivation, reward, cognitive function, maternal, and reproductive behaviors. Dopamine is a neurotransmitter, synthesized in both central nervous system and the periphery, that exerts its actions upon binding to G protein-coupled receptors. Dopamine receptors are widely expressed in the body and function in both the peripheral and the central nervous systems. Dopaminergic signaling pathways are crucial to the maintenance of physiological processes and an unbalanced activity may lead to dysfunctions that are related to neurodegenerative diseases. Unveiling the neurobiology and the molecular mechanisms that underlie these illnesses may contribute to the development of new therapies that could promote a better quality of life for patients worldwide. In this review, we summarize the aspects of dopamine as a catecholaminergic neurotransmitter and discuss dopamine signaling pathways elicited through dopamine receptor activation in normal brain function. Furthermore, we describe the potential involvement of these signaling pathways in evoking the onset and progression of some diseases in the nervous system, such as Parkinson's, Schizophrenia, Huntington's, Attention Deficit and Hyperactivity Disorder, and Addiction. A brief description of new dopaminergic drugs recently approved and under development treatments for these ailments is also provided.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
An extensive literature implicates shared alterations in the reward circuitry in MDD, neurodegenerative disorders, and obesity.
“An extensive literature implicates shared alterations in the reward circuitry in MDD, neurodegenerative disorders, and obesity261-263.”
From Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management (2023) · cites this paper as [263]
Lack of complete understanding of underlying molecular pathology hinders diagnosis and treatment of ADHD.
“One of the reasons that hinder the diagnosis and treatment of this disorder is the lack of complete understanding of the underlying molecular pathology [16].”
From Molecular Characterisation of the Mechanism of Action of Stimulant Drugs Lisdexamfetamine and Methylphenidate on ADHD Neurobiology: A Review (2022) · cites this paper as [16]
DA plays an essential role in mediating regulation of the cortical system, memory, mood, vascular structure, anticipation of events, motivation, behaviour inhibition, decision-making and problem-solving.
“DA plays an essential role in mediating regulation of the cortical system, memory, mood, vascular structure, anticipation of events, motivation, behaviour inhibition, decision-making and problem-solving [16, 81, 82].”
From Molecular Characterisation of the Mechanism of Action of Stimulant Drugs Lisdexamfetamine and Methylphenidate on ADHD Neurobiology: A Review (2022) · cites this paper as [16]
Cites
(1982) · Trends in Neurosciences · doi:10.1016/0166-2236(82)90076-5 · Cited by 9,148 · see citing works
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382 · see citing works
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366 · see citing works
MDS clinical diagnostic criteria for Parkinson’s disease
Postuma, R. B., Berg, D., Stern, M., Poewe, W., Olanow, C. W., Oertel, W., Obeso, J., Marek, K., Litvan, I., Lang, A. E., et al. (2015) · Movement Disorders · doi:10.1002/mds.26424 · Cited by 7,653 · see citing works
Kalia, L. V., & Lang, A. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61393-3 · Cited by 6,412 · see citing works
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469 · see citing works
The worldwide prevalence of ADHD: a systematic review and metaregression analysis
Polanczyk, G., de Lima, M. S., Horta, B. L., Biederman, J., & Rohde, L. A. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.6.942 · Cited by 5,346 · see citing works
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244 · see citing works
Mammalian MAP kinase signalling cascades
Chang, L., & Karin, M. (2001) · Nature · doi:10.1038/35065000 · Cited by 5,118 · see citing works
Predictive reward signal of dopamine neurons
Schultz, W. (1998) · Journal of Neurophysiology · doi:10.1152/jn.1998.80.1.1 · Cited by 4,564 · see citing works
Multiple receptors for dopamine
Kebabian, J. W., & Calne, D. B. (1979) · Nature · doi:10.1038/277093a0 · Cited by 3,742 · see citing works
Glutamate receptor ion channels
Mayer, M. L. (2005) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2005.05.004 · Cited by 3,645 · see citing works
Dopamine receptors: from structure to function
MISSALE, C., NASH, S. R., ROBINSON, S. W., JABER, M., & CARON, M. G. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.1.189 · Cited by 3,633 · see citing works
The Glutamate Receptor Ion Channels
Dingledine, R., Borges, K., Bowie, D., & Traynelis, S. F. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01394-2 · Cited by 3,554 · see citing works
AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY
FEARNLEY, J. M., & LEES, A. J. (1991) · Brain · doi:10.1093/brain/114.5.2283 · Cited by 3,529 · see citing works
The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.
Gibb, W. R., & Lees, A. J. (1988) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.6.745 · Cited by 3,481 · see citing works
Stress and disorders of the stress system
Chrousos, G. P. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.106 · Cited by 3,215 · see citing works
The physiology, signaling, and pharmacology of dopamine receptors
Beaulieu, J.-M., & Gainetdinov, R. R. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.002642 · Cited by 2,763 · see citing works
Targeting the phosphoinositide 3-kinase pathway in cancer
Liu, P., Cheng, H.-L. M., Roberts, T. M., & Zhao, J. J. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2926 · Cited by 2,722 · see citing works
Pierce, K. L., Premont, R. T., & Lefkowitz, R. J. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm908 · Cited by 2,712 · see citing works
Walker, F. O. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60111-1 · Cited by 2,623 · see citing works
Drug abuse: hedonic homeostatic dysregulation
Koob, G. F., & Moal, M. L. (1997) · Science · doi:10.1126/science.278.5335.52 · Cited by 2,535 · see citing works
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
Giros, B., Jaber, M., Jones, S. R., Wightman, R. M., & Caron, M. G. (1996) · Nature · doi:10.1038/379606a0 · Cited by 2,476 · see citing works
Pathological roles of MAPK signaling pathways in human diseases
Kim, E. K., & Choi, E.-J. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.12.009 · Cited by 2,472 · see citing works
Molecular genetics of attention-deficit/hyperactivity disorder
Faraone, S. V., Perlis, R. H., Doyle, A. E., Smoller, J. W., Goralnick, J. J., Holmgren, M. A., & Sklar, P. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.024 · Cited by 2,357 · see citing works
Nagatsu, T., Levitt, M., & Udenfriend, S. (1964) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)93832-9 · Cited by 2,067 · see citing works
Depue, R. A., & Collins, P. F. (1999) · Behavioral and Brain Sciences · doi:10.1017/s0140525x99002046 · Cited by 2,046 · see citing works
Tol, H. H. M. V., Bunzow, J. R., Guan, H., Sunahara, R. K., Seeman, P. M., Niznik, H. B., & Civelli, O. (1991) · Nature · doi:10.1038/350610a0 · Cited by 2,015 · see citing works
Zagrean, L. (2014) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2014.529 · Cited by 1,926 · see citing works
Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry
Kravitz, A. V., Freeze, B. S., Parker, P. R. L., Kay, K., Thwin, M. T., Deisseroth, K., & Kreitzer, A. C. (2010) · Nature · doi:10.1038/nature09159 · Cited by 1,885 · see citing works
Owen, M. J., Sawa, A., & Mortensen, P. B. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01121-6 · Cited by 1,870 · see citing works
Wang, G.-J., Volkow, N. D., Logan, J., Pappas, N. R., Wong, C. T., Zhu, W., Netusll, N., & Fowler, J. S. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03643-6 · Cited by 1,864 · see citing works
Grace, A. A. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90196-u · Cited by 1,831 · see citing works
Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes
Castellanos, F. X., & Tannock, R. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn896 · Cited by 1,827 · see citing works
Ferguson, S. S. G. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01478-9 · Cited by 1,827 · see citing works
Primate anterior cingulate cortex: Where motor control, drive and cognition interface
Paus, T. (2001) · Nature Reviews Neuroscience · doi:10.1038/35077500 · Cited by 1,722 · see citing works
Modulation of Striatal Projection Systems by Dopamine
Gerfen, C. R., & Surmeier, D. J. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113641 · Cited by 1,700 · see citing works
Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis
Simon, V., Czobor, P., Bálint, S., Mészáros, Á., & Bitter, I. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.107.048827 · Cited by 1,601 · see citing works
The primate basal ganglia: Parallel and integrative networks
Haber, S. N. (2003) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2003.10.003 · Cited by 1,479 · see citing works
Ikemoto, S. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.05.004 · Cited by 1,477 · see citing works
The Neuroscience of Natural Rewards: Relevance to Addictive Drugs
Kelley, A. E., & Berridge, K. C. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03306.2002 · Cited by 1,465 · see citing works
MAPK cascade signalling and synaptic plasticity
Thomas, G. M., & Huganir, R. L. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1346 · Cited by 1,454 · see citing works
Ikemoto, S., & Panksepp, J. (1999) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00023-5 · Cited by 1,450 · see citing works
Attention-deficit/hyperactivity disorder: a selective overview.
Biederman, J. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.020 · Cited by 1,439 · see citing works
The mysterious motivational functions of mesolimbic dopamine
Salamone, J. D., & Correa, M. (2012) · Neuron · doi:10.1016/j.neuron.2012.10.021 · Cited by 1,418 · see citing works
β-Arrestins and Cell Signaling
DeWire, S. M., Ahn, S., Lefkowitz, R. J., & Shenoy, S. K. (2007) · Annual Review of Physiology · doi:10.1146/annurev.physiol.69.022405.154749 · Cited by 1,397 · see citing works
G PROTEIN–COUPLED RECEPTOR KINASES
Pitcher, J. A., Freedman, N. J., & Lefkowitz, R. J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.653 · Cited by 1,379 · see citing works
General hospital psychiatry: the Italian experience.
Faraone, S. V., Sergeant, J. A., Gillberg, C., & Biederman, J. (2003) · Europe PMC (PubMed Central) · Cited by 1,277 · see citing works
3,4-Dihydroxyphenylalanine and 5-Hydroxytryptophan as Reserpine Antagonists
Carlsson, A., Lindqvist, M., & Magnusson, T. (1957) · Nature · doi:10.1038/1801200a0 · Cited by 1,272 · see citing works
Affective neuroscience of pleasure: reward in humans and animals
Berridge, K. C., & Kringelbach, M. L. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1099-6 · Cited by 1,254 · see citing works
β-Arrestin: a Protein that Regulates β-adrenergic Receptor Function
Lohse, M. J., Benovic, J., Codina, J., Caron, M. G., & Lefkowitz, R. J. (1990) · Science · doi:10.1126/science.2163110 · Cited by 1,222 · see citing works
Whole-Brain Mapping of Direct Inputs to Midbrain Dopamine Neurons
Watabe‐Uchida, M., Zhu, L., Ogawa, S. K., Vamanrao, A., & Uchida, N. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.017 · Cited by 1,221 · see citing works
Surmeier, D. J., Ding, J., Day, M., Wang, Z., & Shen, W. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.03.008 · Cited by 1,203 · see citing works
Neurobehavioural mechanisms of reward and motivation
Robbins, T. W., & Everitt, B. J. (1996) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(96)80077-8 · Cited by 1,187 · see citing works
Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers
Reitz, C., & Mayeux, R. P. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.12.024 · Cited by 1,180 · see citing works
PI3K/AKT signaling pathway and cancer: an updated review
Martini, M., Santis, M. C. D., Braccini, L., Gulluni, F., & Hirsch, E. (2014) · Annals of Medicine · doi:10.3109/07853890.2014.912836 · Cited by 1,176 · see citing works
Dysconnection in schizophrenia: from abnormal synaptic plasticity to failures of self-monitoring
Stephan, K. E., Friston, K. J., & Frith, C. D. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn176 · Cited by 1,134 · see citing works
Kahn, R. S., Sommer, I. E., Murray, R. M., Meyer‐Lindenberg, A., Weinberger, D. R., Cannon, T. D., O’Donovan, M. C., Correll, C. U., Kane, J. M., van Os, J., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.67 · Cited by 1,132 · see citing works
The role of β-arrestins in the termination and transduction of G-protein-coupled receptor signals
Luttrell, L. M., & Lefkowitz, R. J. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.3.455 · Cited by 1,123 · see citing works
A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci
Chang, D., Nalls, M. A., Hallgrímsdóttir, I. B., Hunkapiller, J., van der Brug, M., Cai, F., International Parkinson's Disease Genomics Consortium, 23andMe Research Team, Kerchner, G. A., Ayalon, G., et al. (2017) · Nature Genetics · doi:10.1038/ng.3955 · Cited by 1,112 · see citing works
Floresco, S. B., West, A. R., Ash, B., Moore, H., & Grace, A. A. (2003) · Nature Neuroscience · doi:10.1038/nn1103 · Cited by 1,106 · see citing works
Carlsson, M. L., & Carlsson, A. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90108-m · Cited by 1,086 · see citing works
Catecholamine Metabolism: A Contemporary View with Implications for Physiology and Medicine
Eisenhofer, G., Kopin, I. J., & Goldstein, D. S. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.3.1 · Cited by 1,072 · see citing works
Graybiel, A. M. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00593-5 · Cited by 1,051 · see citing works
Huntington's disease: a clinical review
Roos, R. A. C. (2010) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-5-40 · Cited by 1,049 · see citing works
Regulation of firing of dopaminergic neurons and control of goal-directed behaviors
Grace, A. A., Floresco, S. B., Goto, Y., & Lodge, D. J. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.03.003 · Cited by 1,034 · see citing works
Koob, G. F., Sanna, P. P., & Bloom, F. E. (1998) · Neuron · doi:10.1016/s0896-6273(00)80557-7 · Cited by 1,026 · see citing works
Kebabian, J. W., Petzold, G. L., & Greengard, P. (1972) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.69.8.2145 · Cited by 1,025 · see citing works
Central mechanisms of motor skill learning
Hikosaka, O., Nakamura, K., Sakai, K., & Nakahara, H. (2002) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(02)00307-0 · Cited by 1,023 · see citing works
Candidate gene studies of ADHD: a meta-analytic review
Gizer, I. R., Ficks, C., & Waldman, I. D. (2009) · Human Genetics · doi:10.1007/s00439-009-0694-x · Cited by 1,020 · see citing works
Clinical progression in Parkinson disease and the neurobiology of axons
Cheng, H., Ulane, C. M., & Burke, R. E. (2010) · Annals of Neurology · doi:10.1002/ana.21995 · Cited by 1,012 · see citing works
Imaging dopamine's role in drug abuse and addiction
Volkow, N. D., Fowler, J. S., Wang, G. J., Baler, R., & Telang, F. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.05.022 · Cited by 988 · see citing works
Dopamine as a Prolactin (PRL) Inhibitor
Ben-Jonathan, N., & Hnasko, R. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.6.0451 · Cited by 983 · see citing works
An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and Behavior
Beaulieu, J., Sotnikova, T. D., Marion, S., Lefkowitz, R. J., Gainetdinov, R. R., & Caron, M. G. (2005) · Cell · doi:10.1016/j.cell.2005.05.012 · Cited by 980 · see citing works
Mesolimbocortical and nigrostriatal dopamine responses to salient non-reward events
Horvitz, J. C. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00019-1 · Cited by 967 · see citing works
Impulsive choice induced in rats by lesions of the nucleus accumbens core
Cardinal, R. N., Pennicott, D. R., Lakmali, C., Sugathapala, Robbins, T. W., & Everitt, B. J. (2001) · Science · doi:10.1126/science.1060818 · Cited by 923 · see citing works
Trace amines: Identification of a family of mammalian G protein-coupled receptors
Borowsky, B., Adham, N., JONES, K. A., Raddatz, R., Artymyshyn, R. P., Ogozalek, K. L., Durkin, M. M., Lakhlani, P. P., Bonini, J. A., Pathirana, S. M., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151105198 · Cited by 912 · see citing works
Dolmetsch, R. E., Pajvani, U., Fife, K., Spotts, J. M., & Greenberg, M. E. (2001) · Science · doi:10.1126/science.1063395 · Cited by 900 · see citing works
Differential effects on motorcortical inhibition induced by blockade of GABA uptake in humans
Werhahn, K. J., Kunesch, E., Noachtar, S., Benecke, R., & Classen, J. (1999) · The Journal of Physiology · doi:10.1111/j.1469-7793.1999.0591t.x · Cited by 887 · see citing works
Role of Serotonin in the Paradoxical Calming Effect of Psychostimulants on Hyperactivity
Gainetdinov, R. R., Wetsel, W. C., Jones, S. R., Levin, E. D., Jaber, M., & Caron, M. G. (1999) · Science · doi:10.1126/science.283.5400.397 · Cited by 885 · see citing works
The Neurobiology of Slow Synaptic Transmission
Greengard, P. (2001) · Science · doi:10.1126/science.294.5544.1024 · Cited by 865 · see citing works
Über humorale übertragbarkeit der Herznervenwirkung
Loewi, O. (1921) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/bf01738910 · Cited by 864 · see citing works
Nonvesicular release of neurotransmitter
Attwell, D., Barbour, B., & Szatkowski, M. S. (1993) · Neuron · doi:10.1016/0896-6273(93)90145-h · Cited by 840 · see citing works
Structure and function of dopamine receptors
Vallone, D., Picetti, R., & Borrelli, E. (2000) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(99)00063-9 · Cited by 821 · see citing works
Direct and indirect pathways of basal ganglia: a critical reappraisal
Calabresi, P., Picconi, B., Tozzi, A., Ghiglieri, V., & Filippo, M. D. (2014) · Nature Neuroscience · doi:10.1038/nn.3743 · Cited by 820 · see citing works
Spector, S., Sjoerdsma, A., & Udenfriend, S. (1965) · PubMed · Cited by 812 · see citing works
Beaulieu, J., Sotnikova, T. D., Yao, W., Kockeritz, L. K., Woodgett, J. R., Gainetdinov, R. R., & Caron, M. G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307921101 · Cited by 792 · see citing works
Non‐motor symptoms in Parkinson’s disease
Poewe, W. H. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02056.x · Cited by 790 · see citing works
Recent Advances in the Molecular Biology of Dopamine Receptors
Gingrich, J. A., & Caron, M. G. (1993) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.16.030193.001503 · Cited by 785 · see citing works
Inositol trisphosphate and calcium signalling mechanisms
Berridge, M. J. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.10.005 · Cited by 777 · see citing works
Role of Transmitter Uptake Mechanisms in Synaptic Neurotransmission
Iversen, L. L. (1971) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1971.tb07066.x · Cited by 776 · see citing works
Bilder, R. M., Volavka, J., Lachman, H. M., & Grace, A. A. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300542 · Cited by 769 · see citing works
The Inositol Trisphosphate/Calcium Signaling Pathway in Health and Disease
Berridge, M. J. (2016) · Physiological Reviews · doi:10.1152/physrev.00006.2016 · Cited by 757 · see citing works
Dopaminergic modulation of synaptic transmission in cortex and striatum
Tritsch, N. X., & Sabatini, B. L. (2012) · Neuron · doi:10.1016/j.neuron.2012.09.023 · Cited by 756 · see citing works
Tyrosine, Phenylalanine, and Catecholamine Synthesis and Function in the Brain2
Fernstrom, J. D., & Fernstrom, M. H. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.6.1539s · Cited by 755 · see citing works
Blood–brain barrier dysfunction in parkinsonian midbrain in vivo
Kortekaas, R., Leenders, K. L., van Oostrom, J. C. H., Vaalburg, W., Bart, J., Willemsen, A. T. M., & Hendrikse, N. H. (2005) · Annals of Neurology · doi:10.1002/ana.20369 · Cited by 733 · see citing works
Cellular Regulation of RGS Proteins: Modulators and Integrators of G Protein Signaling
Hollinger, S., & Hepler, J. R. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.3.527 · Cited by 727 · see citing works
Parkinson disease: from pathology to molecular disease mechanisms
Dexter, D. T., & Jenner, P. G. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.01.018 · Cited by 716 · see citing works
DARPP-32: An Integrator of Neurotransmission
Svenningsson, P., Nishi, A., Fisone, G., Girault, J., Nairn, A. C., & Greengard, P. (2004) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121415 · Cited by 711 · see citing works
Brain receptors for antipsychotic drugs and dopamine: direct binding assays.
Seeman, P. M., Chau-Wong, M., Tedesco, J., & Wong, K. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.11.4376 · Cited by 702 · see citing works
Ross, C. A., Margolis, R. L., Reading, S. A. J., Pletnikov, M. V., & Coyle, J. T. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.015 · Cited by 697 · see citing works
LTP Inhibits LTD in the Hippocampus via Regulation of GSK3β
Peineau, S., Taghibiglou, C., Bradley, C. A., Wong, T. P., Liu, L., Lu, J., Lo, E., Wu, D., Saule, E., Bouschet, T., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.029 · Cited by 690 · see citing works
Alternative splicing directs the expression of two D2 dopamine receptor isoforms
Bruno Giros, A., Sokoloff, P., Martres, M., Riou, J., Emorine, L. J., & Schwartz, J.-C. (1989) · Nature · doi:10.1038/342923a0 · Cited by 685 · see citing works
Morón, J. A., Brockington, A., Wise, R. A., Rocha, B. A., & Hope, B. T. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-02-00389.2002 · Cited by 681 · see citing works
Precursor control of neurotransmitter synthesis.
Wurtman, R. J., Hefti, F. F., & Melamed, E. (1980) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06841-3 · Cited by 674 · see citing works
Lévesque, D., Díaz, J., Pilon, C., Martres, M., Bruno Giros, A., Souil, E., Schott, D., Morgat, J. L., Schwartz, J., & Sokoloff, P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.17.8155 · Cited by 674 · see citing works
Psychobiology of novelty seeking and drug seeking behavior
Bardo, M. T., Donohew, R. L., & Harrington, N. G. (1996) · Behavioural Brain Research · doi:10.1016/0166-4328(95)00203-0 · Cited by 667 · see citing works
The dopamine theory of addiction: 40 years of highs and lows
Nutt, D., Lingford-Hughes, A. R., Erritzøe, D., & Stokes, P. R. A. (2015) · Nature reviews. Neuroscience · doi:10.1038/nrn3939 · Cited by 647 · see citing works
Neuromuscular Junction in Myasthenia Gravis: Decreased Acetylcholine Receptors
Fambrough, D. M., Drachman, D. B., & Satya‐Murti, S. (1973) · Science · doi:10.1126/science.182.4109.293 · Cited by 641 · see citing works
Valjent, E., Pascoli, V., Svenningsson, P., Paul, S., Enslen, H., Corvol, J.-C., Stipanovich, A., Caboche, J., Lombroso, P. J., Nairn, A. C., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408305102 · Cited by 614 · see citing works
Hemmings, H. C., Greengard, P., Tung, H. Y. L., & Cohen, P. (1984) · Nature · doi:10.1038/310503a0 · Cited by 613 · see citing works
Li, D.-W., Sham, P., Owen, M., & He, L. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl152 · Cited by 611 · see citing works
PKB/AKT: functional insights from genetic models
Scheid, M. P., & Woodgett, J. R. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35096067 · Cited by 608 · see citing works
The Role of Genes, Stress, and Dopamine in the Development of Schizophrenia
Howes, O. D., McCutcheon, R. A., Owen, M. J., & Murray, R. M. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.07.014 · Cited by 604 · see citing works
The dopamine D2 receptor: two molecular forms generated by alternative splicing.
Toso, R. D., Sommer, B., Ewert, M., Herb, A., Pritchett, D. B., Bach, A., Shivers, B. D., & SEEBURG, P. H. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08585.x · Cited by 600 · see citing works
Dopaminergic Network Differences in Human Impulsivity
Buckholtz, J. W., Treadway, M. T., Cowan, R. L., Woodward, N. D., Li, R., Ansari, M. S., Baldwin, R. M., Schwartzman, A. N., Shelby, E. S., Smith, C. E., et al. (2010) · Science · doi:10.1126/science.1185778 · Cited by 600 · see citing works
Lee, S., Hjerling-Leffler, J., Zagha, E., Fishell, G., & Rudy, B. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.1869-10.2010 · Cited by 600 · see citing works
Freedman, R. (2003) · New England Journal of Medicine · doi:10.1056/nejmra035458 · Cited by 593 · see citing works
Dimerization: An Emerging Concept for G Protein–Coupled Receptor Ontogeny and Function
Angers, S., Salahpour, A., & Bouvier, M. (2002) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.091701.082314 · Cited by 587 · see citing works
PRESYNAPTIC IONOTROPIC RECEPTORS AND THE CONTROL OF TRANSMITTER RELEASE
MacDermott, A. B., Role, L. W., & Siegelbaum, S. A. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.443 · Cited by 570 · see citing works
Intercellular communication in the brain: Wiring versus volume transmission
Agnati, L. F., Zoli, M., Strömberg, I., & Fuxé, K. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00308-6 · Cited by 569 · see citing works
Biological substrates of reward and aversion: A nucleus accumbens activity hypothesis
Carlezon, W. A., & Thomas, M. J. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.06.075 · Cited by 561 · see citing works
Parkinson, J. A., Olmstead, M. C., Burns, L. H., Robbins, T. W., & Everitt, B. J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-06-02401.1999 · Cited by 555 · see citing works
Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons
Bibb, J. A., Snyder, G. L., Nishi, A., Yan, Z., Meijer, L., Fienberg, A. A., Tsai, L., Kwon, Y. T., Girault, J., Czernik, A. J., et al. (1999) · Nature · doi:10.1038/45251 · Cited by 553 · see citing works
Involvement of the Extracellular Signal-Regulated Kinase Cascade for Cocaine-Rewarding Properties
Valjent, E., Corvol, J., Pagès, C., Besson, M., Maldonado, R. J., & Caboche, J. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-23-08701.2000 · Cited by 548 · see citing works
Provocative tests with psychostimulant drugs in schizophrenia
Lieberman, J. A., Kane, J. M., & Alvir, J. (1987) · Psychopharmacology · doi:10.1007/bf00216006 · Cited by 535 · see citing works
Dopamine Signaling in reward-related behaviors
Baik, J. (2013) · Frontiers in Neural Circuits · doi:10.3389/fncir.2013.00152 · Cited by 534 · see citing works
Protein kinases that phosphorylate activated G protein‐coupled receptors
Premont, R. T., Inglese, J., & Lefkowitz, R. J. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.2.7781920 · Cited by 533 · see citing works
Cell Membrane Resealing by a Vesicular Mechanism Similar to Neurotransmitter Release
Steinhardt, R. A., Bi, G., & Alderton, J. M. (1994) · Science · doi:10.1126/science.7904084 · Cited by 530 · see citing works
Dopamine receptors – IUPHAR R eview 13
Beaulieu, J., Espinoza, S., & Gainetdinov, R. R. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12906 · Cited by 528 · see citing works
Akt/GSK3 Signaling in the Action of Psychotropic Drugs
Beaulieu, J., Gainetdinov, R. R., & Caron, M. G. (2008) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.011008.145634 · Cited by 523 · see citing works
Dopamine: 50 years in perspective
Iversen, S. D., & Iversen, L. L. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.03.002 · Cited by 514 · see citing works
von Euler, U. S. (1946) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1946.tb00368.x · Cited by 512 · see citing works
Roles for nigrostriatal—not just mesocorticolimbic—dopamine in reward and addiction
Wise, R. A. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.06.004 · Cited by 500 · see citing works
Protective and toxic roles of dopamine in Parkinson's disease
Segura‐Aguilar, J., Paris, I. B., Muñoz, P., Ferrari, E., Zecca, L., & Zucca, F. A. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12686 · Cited by 499 · see citing works
Mammalian RGS Proteins: Barbarians at the Gate
Berman, D. M., & Gilman, A. G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.3.1269 · Cited by 497 · see citing works
Physiological Roles of G Protein–Coupled Receptor Kinases and Arrestins
Premont, R. T., & Gainetdinov, R. R. (2007) · Annual Review of Physiology · doi:10.1146/annurev.physiol.69.022405.154731 · Cited by 495 · see citing works
Rashid, A. J., So, C. H., Kong, M. M. C., Furtak, T., El-Ghundi, M., Cheng, R., O’Dowd, B. F., & George, S. R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604049104 · Cited by 492 · see citing works
DARPP-32: Regulator of the Efficacy of Dopaminergic Neurotransmission
Fienberg, A. A., Hiroi, N., Mermelstein, P. G., Song, W., Snyder, G. L., Nishi, A., Chéramy, A., O'Callaghan, J. P., Miller, D. B., Cole, D. G., et al. (1998) · Science · doi:10.1126/science.281.5378.838 · Cited by 491 · see citing works
GSK-3: Functional Insights from Cell Biology and Animal Models
Kaidanovich‐Beilin, O., & Woodgett, J. R. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00040 · Cited by 490 · see citing works
Nicotinic acetylcholine binding sites in Alzheimer's disease
Whitehouse, P. J., Martino, A. M., Antuono, P., Lowenstein, P. R., Coyle, J. T., Price, D. L., & Kellar, K. J. (1986) · Brain Research · doi:10.1016/0006-8993(86)90819-x · Cited by 485 · see citing works
Über humorale Übertragbarkeit der Herznervenwirkung
Loewi, O., & Navratil, E. (1924) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/bf01722757 · Cited by 480 · see citing works
Stimulation of locomotor activity following injection of dopamine into the nucleus accumbens
Pijnenburg, A. J. J., & van Rossum, J. M. (1973) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1973.tb09995.x · Cited by 480 · see citing works
Mechanism of Transport and Storage of Neurotransmitter
Kanner, B. I., & Schuldiner, S. (1987) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238709082546 · Cited by 477 · see citing works
Efflux of dopamine from the synaptic cleft in the nucleus accumbens of the rat brain
Garris, P. A., Ciolkowski, E. L., Pastore, P., & Wightman, R. M. (1994) · Journal of Neuroscience · doi:10.1523/jneurosci.14-10-06084.1994 · Cited by 475 · see citing works
Pedersen, C. A., Caldwell, J. D., Walker, C., Ayers, G., & Mason, G. A. (1994) · Behavioral Neuroscience · doi:10.1037/0735-7044.108.6.1163 · Cited by 475 · see citing works
The structural basis of arrestin-mediated regulation of G-protein-coupled receptors
Gurevich, V. V., & Gurevich, E. V. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.09.008 · Cited by 473 · see citing works
Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism
Hauser, D. N., & Hastings, T. G. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.10.011 · Cited by 470 · see citing works
Self-citationDopamine D1 and D2 Receptor Co-activation Generates a Novel Phospholipase C-mediated Calcium Signal
Lee, S. P., So, C. H., Rashid, A. J., Varghese, G. K., Cheng, R., Lança, A. J., O’Dowd, B. F., & George, S. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401923200 · Cited by 468 · see citing works
Restless legs syndrome: Revisiting the dopamine hypothesis from the spinal cord perspective
Clemens, S., Rye, D., & Hochman, S. (2006) · Neurology · doi:10.1212/01.wnl.0000223316.53428.c9 · Cited by 465 · see citing works
Genetics in Parkinson disease: Mendelian versus non‐Mendelian inheritance
Hernandez, D. G., Reed, X., & Singleton, A. B. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13593 · Cited by 448 · see citing works
The history of attention deficit hyperactivity disorder
Lange, K. W., Reichl, S., Lange, K. M., Tucha, L., & Tucha, O. (2010) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-010-0045-8 · Cited by 446 · see citing works
Hernández-López, S., Tkatch, T., Perez-Garci, E., Galarraga, E., Bargas, J., Hamm, H., & Surmeier, D. J. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-08987.2000 · Cited by 443 · see citing works
Elliott, T. R. (1905) · The Journal of Physiology · doi:10.1113/jphysiol.1905.sp001093 · Cited by 438 · see citing works
The neurodevelopmental basis of sex differences in schizophrenia
Castle, D. J., & Murray, R. M. (1991) · Psychological Medicine · doi:10.1017/s0033291700022194 · Cited by 437 · see citing works
Attention-deficit/hyperactivity disorder and adverse health outcomes
Nigg, J. T. (2013) · Clinical Psychology Review · doi:10.1016/j.cpr.2012.11.005 · Cited by 436 · see citing works
Liu, F., Wan, Q., Pristupa, Z. B., Yu, X., Wang, Y. T., & Niznik, H. B. (2000) · Nature · doi:10.1038/35002014 · Cited by 430 · see citing works
Bidirectional Regulation of DARPP-32 Phosphorylation by Dopamine
Nishi, A., Snyder, G. L., & Greengard, P. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-21-08147.1997 · Cited by 424 · see citing works
Dopamine-Sensitive Adenyl Cyclase: Possible Role in Synaptic Transmission
Kebabian, J. W., & Greengard, P. (1971) · Science · doi:10.1126/science.174.4016.1346 · Cited by 422 · see citing works
Addiction and Brain Reward and Antireward Pathways
Gardner, E. L. (2011) · Advances in psychosomatic medicine · doi:10.1159/000324065 · Cited by 419 · see citing works
Shaywitz, B. A., Yager, R. D., & Klopper, J. H. (1976) · Science · doi:10.1126/science.942800 · Cited by 405 · see citing works
Champagne, F. A., Chretien, P., Stevenson, C. W., Zhang, T. Y., Gratton, A., & Meaney, M. J. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.5322-03.2004 · Cited by 398 · see citing works
The Dopamine Transporter and Attention-Deficit/Hyperactivity Disorder
Madras, B. K., Miller, G. M., & Fischman, A. J. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.011 · Cited by 393 · see citing works
Common cellular and molecular mechanisms in obesity and drug addiction
Kenny, P. J. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3105 · Cited by 382 · see citing works
Exercise as a novel treatment for drug addiction: A neurobiological and stage-dependent hypothesis
Lynch, W. J., Peterson, A. B., Sánchez, V., Abel, J. M., & Smith, M. A. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.06.011 · Cited by 377 · see citing works
GPCR desensitization: Acute and prolonged phases
Rajagopal, S., & Shenoy, S. K. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.01.024 · Cited by 376 · see citing works
Maeda, K., Sugino, H., Akazawa, H., Amada, N., Shimada, J., Futamura, T., Yamashita, H., Ito, N., McQuade, R. D., Mørk, A., et al. (2014) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.213793 · Cited by 372 · see citing works
Dopamine transporters and neuronal injury
Miller, G. W., Gainetdinov, R. R., Levey, A. I., & Caron, M. G. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01379-6 · Cited by 371 · see citing works
Damsma, G., Pfaus, J. G., Wenkstern, D., Phillips, A. G., & al, E. (1992) · Behavioral Neuroscience · doi:10.1037//0735-7044.106.1.181 · Cited by 370 · see citing works
Damsma, G., Pfaus, J. G., Wenkstern, D., Phillips, A. G., & Fibiger, H. C. (1992) · Behavioral Neuroscience · doi:10.1037/0735-7044.106.1.181 · Cited by 370 · see citing works
Kiss, B., Horváth, A., Némethy, Z., Schmidt, E. M., Laszlovszky, I., Bugovics, G., Fazekas, K., Hornok, K., Orosz, S., Gyertyán, I., et al. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.160432 · Cited by 368 · see citing works
Revel, F. G., Moreau, J., Gainetdinov, R. R., Bradaïa, A., Sotnikova, T. D., Mory, R., Durkin, S., Zbinden, K. G., Norcross, R. D., Meyer, C. A., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103029108 · Cited by 366 · see citing works
Arnsten, A. F., & Dudley, A. G. (2005) · Behavioral and Brain Functions · doi:10.1186/1744-9081-1-2 · Cited by 363 · see citing works
The basal ganglia in Parkinson's disease: Current concepts and unexplained observations
Obeso, J. A., Marin, C., Rodriguez-Oroz, C., Blesa, J., Benitez-Temiño, B., Mena-Segovia, J., Rodríguez, M., & Olanow, C. W. (2009) · Annals of Neurology · doi:10.1002/ana.21481 · Cited by 359 · see citing works
Dopaminergic Modulation of Arousal in Drosophila
Waldowski, R. A., van Swinderen, B., & Greenspan, R. J. (2005) · Current Biology · doi:10.1016/j.cub.2005.05.025 · Cited by 359 · see citing works
Motivational systems and the neural circuitry of maternal behavior in the rat
Numan, M. (2007) · Developmental Psychobiology · doi:10.1002/dev.20198 · Cited by 358 · see citing works
Preparation and properties of a homogeneous aromatic l-amino acid decarboxylase from hog kidney
Christenson, J. G., Dairman, W. M., & Udenfriend, S. (1970) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(70)90144-x · Cited by 357 · see citing works
Activation of NMDA receptors induces dephosphorylation of DARPP-32 in rat striatal slices
Halpain, S., Girault, J.-A., & Greengard, P. (1990) · Nature · doi:10.1038/343369a0 · Cited by 357 · see citing works
Dopaminergic modulation of gap junction permeability between amacrine cells in mammalian retina
Hampson, E. C. G. M., Vaney, D., & Weiler, R. (1992) · Journal of Neuroscience · doi:10.1523/jneurosci.12-12-04911.1992 · Cited by 356 · see citing works
Dopamine supersensitivity correlates with D2 High states, implying many paths to psychosis
Seeman, P. M., Weinshenker, D., Quirion, R., Srivastava, L. K., Bhardwaj, S. K., Grandy, D. K., Premont, R. T., Sotnikova, T. D., Boksa, P., El-Ghundi, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409766102 · Cited by 353 · see citing works
The basal ganglia and cognitive pattern generators
Graybiel, A. M. (1997) · Schizophrenia Bulletin · doi:10.1093/schbul/23.3.459 · Cited by 351 · see citing works
Trace Amine-Associated Receptor 1 Modulates Dopaminergic Activity
Lindemann, L., Meyer, C. A., Jeanneau, K., Bradaïa, A., Ozmen, L., Bluethmann, H., Bettler, B., Wettstein, J. G., Borroni, E., Moreau, J., et al. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.132647 · Cited by 350 · see citing works
A dopamine- and cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions
Walaas, S. I., Aswad, D. W., & Greengard, P. (1983) · Nature · doi:10.1038/301069a0 · Cited by 345 · see citing works
The Yin and Yang of dopamine release: a new perspective
GOTO, Y., OTANI, S., & GRACE, A. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.07.007 · Cited by 342 · see citing works
A Comparison of the Vascular Dopamine Receptor with Other Dopamine Receptors
Goldberg, L. I., Volkman, P. H., & Kohli, J. D. (1978) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.18.040178.000421 · Cited by 337 · see citing works
Dopamine, a neurotransmitter, influences the immune system
Basu, S., & Dasgupta, P. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00176-9 · Cited by 335 · see citing works
Human Trials of Stem Cell-Derived Dopamine Neurons for Parkinson’s Disease: Dawn of a New Era
Barker, R. A., Parmar, M., Studer, L., & Takahashi, J. B. (2017) · Cell stem cell · doi:10.1016/j.stem.2017.09.014 · Cited by 334 · see citing works
Dale, H. H. (1935) · PubMed · Cited by 330 · see citing works
G protein‐coupled receptor hetero‐dimerization: contribution to pharmacology and function
Milligan, G. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00169.x · Cited by 326 · see citing works
Proportional Release of Norepinephrine and Dopamine-β-Hydroxylase from Sympathetic Nerves
Weinshilboum, R. M., Thoa, N. B., Johnson, D. G., Kopin, I. J., & Axelrod, J. (1971) · Science · doi:10.1126/science.174.4016.1349 · Cited by 323 · see citing works
Negative Symptoms and the Failure to Represent the Expected Reward Value of Actions
Gold, J. M. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.1269 · Cited by 319 · see citing works
Autoradiographic localization of D1 dopamine receptors in the rat brain with [3H]SCH 23390
Savasta, M., Dubois, A., & Scatton, B. (1986) · Brain Research · doi:10.1016/0006-8993(86)90749-3 · Cited by 318 · see citing works
Trace amine-associated receptors and their ligands
Zucchi, R., Chiellini, G., Scanlan, T. S., & Grandy, D. K. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706948 · Cited by 314 · see citing works
NMDA-mediated activation of the tyrosine phosphatase STEP regulates the duration of ERK signaling
Paul, S., Nairn, A. C., Wang, P., & Lombroso, P. J. (2002) · Nature Neuroscience · doi:10.1038/nn989 · Cited by 314 · see citing works
Calcium/calmodulin-dependent protein kinase II and synaptic plasticity
Colbran, R. J., & Brown, A. M. (2004) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2004.05.008 · Cited by 307 · see citing works
Kim, K., Valenzano, K. J., Robinson, S. W., Yao, W.-D., Barak, L. S., & Caron, M. G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106728200 · Cited by 306 · see citing works
Hasue, R. H., & Shammah‐Lagnado, S. J. (2002) · The Journal of Comparative Neurology · doi:10.1002/cne.10420 · Cited by 306 · see citing works
Evidence of an incerto-hypothalamic dopamine neurone system in the rat
Bjo¨rklund, A., Lindvall, O., & Nobin, A. (1975) · Brain Research · doi:10.1016/0006-8993(75)90131-6 · Cited by 303 · see citing works
G-protein-coupled receptors: turn-ons and turn-offs
Carman, C. V., & Benovic, J. (1998) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(98)80058-5 · Cited by 303 · see citing works
An integrative perspective on the role of dopamine in schizophrenia
Maia, T. V., & Frank, M. J. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.05.021 · Cited by 293 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Teleanu, R. I., Niculescu, A.-G., Roza, E., Vladâcenco, O. A., Grumezescu, A. M., & Teleanu, D. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23115954 · Cited by 630 · see citing works
Next-generation GRAB sensors for monitoring dopaminergic activity in vivo
Sun, F., Zhou, J., Dai, B., Qian, T., Zeng, J., Li, X., Zhuo, Y., Zhang, Y., Wang, Y., Cheng, Q., et al. (2020) · Nature Methods · doi:10.1038/s41592-020-00981-9 · Cited by 483 · see citing works
Dopamine in Parkinson's disease
Latif, S., Jahangeer, M., Razia, D. E. M., Ashiq, M., Ghaffar, A., Akram, M., Allam, A. E., Bouyahya, A., Garipova, L., Shariati, M. A., et al. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.08.009 · Cited by 348 · see citing works
Berk, M., Köhler‐Forsberg, O., Turner, M., Penninx, B. W. J. H., Wrobel, A., Firth, J., Loughman, A., Reavley, N. J., McGrath, J. J., Momen, N. C., et al. (2023) · World Psychiatry · doi:10.1002/wps.21110 · Cited by 336 · see citing works
Electrochemical Biosensing of Dopamine Neurotransmitter: A Review
Lakard, S., Pavel, I., & Lakard, B. (2021) · Biosensors · doi:10.3390/bios11060179 · Cited by 245 · see citing works
Emerging porous organic polymers for biomedical applications
Zhu, Y., Xu, P., Zhang, X., & Wu, D. (2022) · Chemical Society Reviews · doi:10.1039/d1cs00871d · Cited by 238 · see citing works
Microbial-derived metabolites as a risk factor of age-related cognitive decline and dementia
Connell, E., Le Gall, G., Pontifex, M. G., Sami, S., Cryan, J. F., Clarke, G., Müller, M., & Vauzour, D. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00548-6 · Cited by 208 · see citing works
Chen, Z., Mu, X., Han, Z., Yang, S., Zhang, C., Guo, Z., Bai, Y., & He, W. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.9b09181 · Cited by 203 · see citing works
Brain Neurotransmitter Modulation by Gut Microbiota in Anxiety and Depression
Huang, F., & Wu, X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.649103 · Cited by 183 · see citing works
Kumar, A., Sreedharan, S., Kashyap, A. K., Singh, P., & Ramchiary, N. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e08669 · Cited by 161 · see citing works
Chen, M., Ruan, G., Chen, L., Ying, S., Li, G., Xu, F., Xiao, Z., Tian, Y., Lv, L., Ping, Y., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.817100 · Cited by 159 · see citing works
Mhanna, A., Martini, N., Hmaydoosh, G., Hamwi, G., Jarjanazi, M., Zaifah, G., Kazzazo, R., Mohamad, A. H., & Alshehabi, Z. (2024) · Medicine · doi:10.1097/md.0000000000037114 · Cited by 144 · see citing works
Ostadkarampour, M., & Putnins, E. E. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.676239 · Cited by 133 · see citing works
Neurotransmitters in Prevention and Treatment of Alzheimer’s Disease
Yang, Z., Zou, Y., & Wang, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043841 · Cited by 132 · see citing works
Diabetes and Cognitive Impairment: A Role for Glucotoxicity and Dopaminergic Dysfunction
Pignalosa, F. C., Desiderio, A., Mirra, P., Nigro, C., Perruolo, G., Ulianich, L., Formisano, P., Bèguinot, F., Miele, C., Napoli, R., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212366 · Cited by 129 · see citing works
Fluorescent Biosensors for Neurotransmission and Neuromodulation: Engineering and Applications
Leopold, A. V., Shcherbakova, D. M., & Verkhusha, V. V. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00474 · Cited by 120 · see citing works
The receptor hypothesis and the pathogenesis of depression: Genetic bases and biological correlates
Wang, H., Wang, Z., & Chen, N. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105542 · Cited by 117 · see citing works
Dopamine: an immune transmitter
Broome, S. T., Louangaphay, K., Keay, K. A., Leggio, G. M., Musumeci, G., & Castorina, A. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.284976 · Cited by 109 · see citing works
Functional catalytic nanoparticles (nanozymes) for sensing
Ouyang, Y., O’Hagan, M., & Willner, I. (2022) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2022.114768 · Cited by 109 · see citing works
Marques, A., Marconcin, P., Werneck, A. O., Ferrari, G., Gouveia, É. R., Kliegel, M., Peralta, M., & Ihle, A. (2021) · Brain Sciences · doi:10.3390/brainsci11070829 · Cited by 108 · see citing works
Nguyen, N. T. T., Nguyen, L. M., Nguyen, T. T. T., Tran, U. P. N., Nguyen, D. T. C., & Tran, T. V. (2022) · Chemosphere · doi:10.1016/j.chemosphere.2022.137301 · Cited by 108 · see citing works
Neuroprotective Polyphenols: A Modulatory Action on Neurotransmitter Pathways
Rębas, E., Rzajew, J., Radzik, T., & Żylińska, L. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200106155127 · Cited by 107 · see citing works
Disrupted sleep and circadian rhythms in schizophrenia and their interaction with dopamine signaling
Ashton, A., & Jagannath, A. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00636 · Cited by 106 · see citing works
The Microbiota–Gut–Brain Axis: Psychoneuroimmunological Insights
Marano, G., Mazza, M., Lisci, F. M., Ciliberto, M., Traversi, G., Kotzalidis, G. D., Berardis, D. D., Laterza, L., Sani, G., Gasbarrini, A., et al. (2023) · Nutrients · doi:10.3390/nu15061496 · Cited by 109 · see citing works
Sex Differences in Dopamine Receptors and Relevance to Neuropsychiatric Disorders
Williams, O. O. F., Coppolino, M., George, S. R., & Perreault, M. L. (2021) · Brain Sciences · doi:10.3390/brainsci11091199 · Cited by 99 · see citing works
Bueno-Carrasco, M. T., Cuéllar, J., Flydal, M. I., Santiago, C. A., Kråkenes, T.-A., Kleppe, R., López‐Blanco, J. R., Marcilla, M., Teigen, K., Alvira, S., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27657-y · Cited by 102 · see citing works
MacDonald, H. J., Kleppe, R., Szigetvari, P. D., & Haavik, J. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1492126 · Cited by 114 · see citing works
Role of Descending Dopaminergic Pathways in Pain Modulation
Li, C., Liu, S., Lu, X., & Tao, F. (2019) · Current Neuropharmacology · doi:10.2174/1570159x17666190430102531 · Cited by 100 · see citing works
Yoshida, J., Oñate, M., Khatami, L., Vera, J. R., Farzan Nadim, A., & Khodakhah, K. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.1535-22.2022 · Cited by 96 · see citing works
Xu, H., & Yang, F. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02233-0 · Cited by 98 · see citing works
Come Fly with Me: An overview of dopamine receptors in Drosophila melanogaster
Karam, C. S., Jones, S. K., & Javitch, J. A. (2019) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13277 · Cited by 90 · see citing works
Gut–Brain–Skin Axis in Psoriasis: A Review
Chen, G., Zai-ming, C., Fan, X., Jin, Y., Li, X., Wu, S.-R., Ge, W., Lv, C.-H., Wang, Y.-K., & Chen, J. (2020) · Dermatology and Therapy · doi:10.1007/s13555-020-00466-9 · Cited by 90 · see citing works
Żwierełło, W., Maruszewska, A., Skórka-Majewicz, M., Goschorska, M., Baranowska‐Bosiacka, I., Dec, K., Styburski, D., Nowakowska, A., & Gutowska, I. (2019) · Chemosphere · doi:10.1016/j.chemosphere.2019.124901 · Cited by 89 · see citing works
The modulatory role of dopamine receptors in brain neuroinflammation
Xia, Q.-P., Cheng, Z.-Y., & He, L. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.105908 · Cited by 85 · see citing works
The Promise of the Zebrafish Model for Parkinson’s Disease: Today’s Science and Tomorrow’s Treatment
Razali, K., Othman, N., Nasir, M. H. M., Doolaanea, A. A., Kumar, J., Ibrahim, W. N., Ibrahim, N. M., & Mohamed, W. M. Y. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.655550 · Cited by 85 · see citing works
Li, R., Guo, W., Lei, L., Zhang, L., Liu, Y., Han, J. Z., Chen, L., & Zhou, B. (2019) · Environment International · doi:10.1016/j.envint.2019.105293 · Cited by 84 · see citing works
The neurodevelopmental role of dopaminergic signaling in neurological disorders
Cai, Y., Xing, L., Yang, T., Chai, R., Wang, J., Bao, J., Shen, W., Ding, S., & Chen, G. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135540 · Cited by 84 · see citing works
Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis
Bruno, A., Dolcetti, E., Rizzo, F., Fresegna, D., Musella, A., Gentile, A., Vito, F. D., Caioli, S., Guadalupi, L., Bullitta, S., et al. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00169 · Cited by 65 · see citing works
A gut-secreted peptide suppresses arousability from sleep
Titos, I., Juginović, A., Vaccaro, A., Nambara, K., Gorelik, P., Mazor, O., & Rogulja, D. (2023) · Cell · doi:10.1016/j.cell.2023.02.022 · Cited by 80 · see citing works
Interaction of neurotransmitters and neurochemicals with lymphocytes
Kerage, D., Sloan, E. K., Mattarollo, S. R., & McCombe, P. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.04.006 · Cited by 80 · see citing works
Nanozyme-based strategies for efficient theranostics of brain diseases
Xu, R., Zhang, S., Wang, P., Zhang, R., Lin, P., Wang, Y., Gao, L., Wei, H., Zhang, X., Ling, D., et al. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215519 · Cited by 77 · see citing works
Matrone, G. M., van Doremaele, E. R. W., Surendran, A., Laswick, Z., Griggs, S., Ye, G., McCulloch, I. A., Santoro, F., Rivnay, J., & van de Burgt, Y. (2024) · Nature Communications · doi:10.1038/s41467-024-47226-3 · Cited by 77 · see citing works
Li, L., Yuan, J., Dai, Z., Song, X., Tu, Q., Cui, X., Zhai, S., Chen, X., He, Z., Fang, B., et al. (2024) · Advanced Materials · doi:10.1002/adma.202409329 · Cited by 78 · see citing works
Ultrasensitive dopamine detection with graphene aptasensor multitransistor arrays
Abrantes, M., Rodrigues, D., Domingues, T., Nemala, S. S., Monteiro, P., Borme, J., Alpuim, P., & Jacinto, L. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01695-0 · Cited by 74 · see citing works
The role of oxytocin and vasopressin dysfunction in cognitive impairment and mental disorders
Abramova, O. V., Zorkina, Y., Ushakova, V. M., Zubkov, E. A., Morozova, A. Y., & Chekhonin, V. P. (2020) · Neuropeptides · doi:10.1016/j.npep.2020.102079 · Cited by 74 · see citing works
The role of dopamine in NLRP3 inflammasome inhibition: Implications for neurodegenerative diseases
Possemato, E., Barbera, L. L., Nobili, A., Krashia, P., & D’Amelio, M. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101907 · Cited by 75 · see citing works
Şenel, M., Dervisevic, M., Alhassen, S., Alachkar, A., & Voelcker, N. H. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c00835 · Cited by 71 · see citing works
Quintero, J., Gutiérrez-Casares, J. R., & Álamo, C. (2022) · Neurology and Therapy · doi:10.1007/s40120-022-00392-2 · Cited by 70 · see citing works
“the diagnosis and treatment of this disorder is the lack of complete understanding of the underlying molecular pathology [16].”
BackgroundNiu, B., Liu, M., Li, X., Guo, H., & Chen, Z. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c22586 · Cited by 70 · see citing works
3D printed electrochemical devices for bio-chemical sensing: A review
Sharma, A., Faber, H., Khosla, A., & Anthopoulos, T. (2023) · Materials science & engineering. R, Reports · doi:10.1016/j.mser.2023.100754 · Cited by 55 · see citing works
Nicotine’s effect on cognition, a friend or foe?
Wang, Q., Du, W., Wang, H., Geng, P., Sun, Y., Zhang, J., Wang, W., & Jin, X. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110723 · Cited by 66 · see citing works
The Formation and Function of the VTA Dopamine System
Hou, G., Hao, M., Duan, J., & Han, M.-H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073875 · Cited by 65 · see citing works
Tu, X., Li, Y., Chen, Q.-L., Shen, Y., & Liu, Z. (2020) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2020.111014 · Cited by 65 · see citing works
Aboushaar, N., & Serrano, N. (2024) · Frontiers in Pain Research · doi:10.3389/fpain.2024.1445280 · Cited by 70 · see citing works
A Potential Role for Neuroinflammation in ADHD
Vázquez-González, D., Carreón-Trujillo, S., Álvarez‐Arellano, L., Abarca-Merlin, D. M., Domínguez-López, P., Salazar–García, M., & Corona, J. C. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-7376-5_15 · Cited by 64 · see citing works
Structure of the human dopamine transporter and mechanisms of inhibition
Srivastava, D. K., Navratna, V., Tosh, D. K., Chinn, A., Sk, M. F., Tajkhorshid, E., Jacobson, K. A., & Gouaux, E. (2024) · Nature · doi:10.1038/s41586-024-07739-9 · Cited by 61 · see citing works
Chakraborty, P., Dey, A., Gopalakrishnan, A. V., Swati, K., Ojha, S. K., Prakash, A., Kumar, D., Ambasta, R. K., Jha, N. K., Jha, S. K., et al. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101838 · Cited by 58 · see citing works
Leau, S.-A., Lete, C., & Lupu, S. (2023) · Chemosensors · doi:10.3390/chemosensors11030179 · Cited by 58 · see citing works
Gholipour, A., & Rahmani, S. (2023) · Journal of Fluorescence · doi:10.1007/s10895-023-03483-x · Cited by 56 · see citing works
Huber, N., Korhonen, S., Hoffmann, D. B., Leskelä, S., Rostalski, H., Remes, A. M., Honkakoski, P., Solje, E., & Haapasalo, A. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01384-8 · Cited by 55 · see citing works
Fan, S., Lin, W., Huang, Y., Xia, J., Xu, J., Zhang, J., & Pi, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.829712 · Cited by 55 · see citing works
Dopamine Receptors: Is It Possible to Become a Therapeutic Target for Depression?
Zhao, F., Cheng, Z., Piao, J., Cui, R., & Li, B. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.947785 · Cited by 58 · see citing works
Mechanisms and Potential Benefits of Neuroprotective Agents in Neurological Health
Pekdemir, B., Raposo, A., Saraiva, A., Lima, M. J., Alsharari, Z. D., BinMowyna, M. N., & Karav, S. (2024) · Nutrients · doi:10.3390/nu16244368 · Cited by 64 · see citing works
Roostalu, U., Salinas, C. B. G., Thorbek, D. D., Skytte, J. L., Fabricius, K., Barkholt, P., John, L. M., Jurtz, V. I., Knudsen, L. B., Jelsing, J., et al. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.042200 · Cited by 54 · see citing works
Dopamine activates NF-κB and primes the NLRP3 inflammasome in primary human macrophages
Nolan, R. A., Reeb, K. L., Rong, Y., Matt, S. M., Johnson, H. S., Runner, K., & Gaskill, P. J. (2019) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2019.100030 · Cited by 54 · see citing works
Central Insulin Modulates Dopamine Signaling in the Human Striatum
Kullmann, S., Blum, D., Jaghutriz, B. A., Gassenmaier, C., Bender, B., Häring, H., Reischl, G., Preissl, H. T., la Fougère, C. J., Fritsche, A., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab410 · Cited by 54 · see citing works
Advanced functional materials for electrochemical dopamine sensors
Burns, G., Ali, M. Y., & Howlader, M. M. R. (2023) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2023.117367 · Cited by 52 · see citing works
The Impact of Neurotransmitters on the Neurobiology of Neurodegenerative Diseases
Davis, S. E., Cirincione, A. B., Jiménez-Torres, A. C., & Zhu, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015340 · Cited by 52 · see citing works
Recent advances with 5‐HT3 modulators for neuropsychiatric and gastrointestinal disorders
Jůza, R., Vlček, P., Mezeiová, E., Musílek, K., Soukup, O., & Korábečný, J. (2020) · Medicinal Research Reviews · doi:10.1002/med.21666 · Cited by 52 · see citing works
Ratnam, K. V., Manjunatha, H., Janardan, S., Naidu, K. C. B., & Ramesh, S. (2020) · Sensors International · doi:10.1016/j.sintl.2020.100047 · Cited by 50 · see citing works
Ren, X., Zhang, Q., Yang, J., Zhang, X., Zhang, X., Zhang, Y., Huang, L., Xu, C., Ge, Y., Chen, H., et al. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.1c01108 · Cited by 50 · see citing works
The Development of the Mesoprefrontal Dopaminergic System in Health and Disease
Islam, K. U. S., Meli, N., & Blaess, S. (2021) · Frontiers in Neural Circuits · doi:10.3389/fncir.2021.746582 · Cited by 50 · see citing works
Wu, L.-Y., Dang, Y., Liang, L.-X., Gong, Y.-C., Zeeshan, M., Qian, Z. M., Geiger, S. D., Vaughn, M. G., Zhou, Y., Li, Q., et al. (2022) · Chemosphere · doi:10.1016/j.chemosphere.2022.134234 · Cited by 48 · see citing works
Naoi, M., Wu, Y., Maruyama, W., & Shamoto‐Nagai, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26072916 · Cited by 52 · see citing works
Imidacloprid and thiamethoxam affect synaptic transmission in zebrafish
Zhang, J., Ma, D.-D., Xiong, Q., Qiu, S., Huang, G., Shi, W., & Ying, G. (2021) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2021.112917 · Cited by 48 · see citing works
Kanarik, M., Grimm, O., Mota, N. R., Reif, A., & Harro, J. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104757 · Cited by 48 · see citing works
Dopamine Receptors in Cancer: Are They Valid Therapeutic Targets?
Rosas-Cruz, A., Salinas-Jazmín, N., & Velasco-Velázquez, M. A. (2021) · Technology in Cancer Research & Treatment · doi:10.1177/15330338211027913 · Cited by 47 · see citing works
Speranza, L., Miniaci, M. C., & Volpicelli, F. (2025) · Biomedicines · doi:10.3390/biomedicines13020492 · Cited by 46 · see citing works
Dental Pulp-Derived Mesenchymal Stem Cells for Modeling Genetic Disorders
Masuda, K., Han, X., Kato, H., Sato, H., Zhang, Y., Sun, X., Hirofuji, Y., Yamaza, H., Yamada, A., & Fukumoto, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052269 · Cited by 48 · see citing works
Iglesias‐Vázquez, L., Binter, A.-C., Canals, J., Hernández‐Martínez, C., Voltas, N., Ambrós, A., Fernández‐Barrés, S., Pérez‐Crespo, L., Guxens, M., & Arija, V. (2022) · Environmental Research · doi:10.1016/j.envres.2022.113501 · Cited by 45 · see citing works
Purkinje cell dopaminergic inputs to astrocytes regulate cerebellar-dependent behavior
Li, C., Saliba, N. B., Martin, H., Losurdo, N. A., Kolahdouzan, K., Siddiqui, R., Medeiros, D., & Li, W. (2023) · Nature Communications · doi:10.1038/s41467-023-37319-w · Cited by 46 · see citing works
Yu, T., Zhou, G., Cai, Z., Liang, W., Du, Y., & Wang, W. (2021) · Aquatic Toxicology · doi:10.1016/j.aquatox.2021.105926 · Cited by 45 · see citing works
Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition
Papa, A., Pasquini, S., Contri, C., Gemma, S., Campiani, G., Butini, S., Varani, K., & Vincenzi, F. (2022) · Cells · doi:10.3390/cells11030471 · Cited by 45 · see citing works
Getting more out of the zebrafish light dark transition test
Haigis, A.-C., Ottermanns, R., Schiwy, A., Hollert, H., & Legradi, J. (2022) · Chemosphere · doi:10.1016/j.chemosphere.2022.133863 · Cited by 44 · see citing works
Huang, J., Chai, X., Wu, Y., Hou, Y., Li, C., Xue, Y., Pan, J., Zhao, Y., Su, A., Zhu, X., et al. (2022) · The FASEB Journal · doi:10.1096/fj.202101469rr · Cited by 44 · see citing works
Liu, J., Fang, Y., Cui, L.-X., Wang, Z., Luo, Y., Gao, C., Ge, W., Huang, T., Wen, J., & Zhou, T. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112861 · Cited by 46 · see citing works
Apathy and Motivation: Biological Basis and Drug Treatment
Costello, H., Masud Husain, B., & Roiser, J. P. (2023) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-022423-014645 · Cited by 46 · see citing works
Humińska‐Lisowska, K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111602 · Cited by 52 · see citing works
Sex and strain differences in dynamic and static properties of the mesolimbic dopamine system
Rivera-Garcia, M. T., McCane, A. M., Chowdhury, T. G., Wallin-Miller, K. G., & Moghaddam, B. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0765-1 · Cited by 43 · see citing works
Gangopadhyay, A., Ibrahim, R., Theberge, K., May, M. A., & Houseknecht, K. L. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1042442 · Cited by 43 · see citing works
Govindula, A., Ranadive, N., Nampoothiri, M., Rao, C. M., Arora, D. S., & Mudgal, J. (2023) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-023-10064-z · Cited by 44 · see citing works
Lisco, G., Tullio, A. D., Iovino, M., Disoteo, O., Guastamacchia, E., Giagulli, V. A., & Triggiani, V. (2023) · Biomedicines · doi:10.3390/biomedicines11112993 · Cited by 44 · see citing works
The organic cation transporter 2 regulates dopamine D1 receptor signaling at the Golgi apparatus
Puri, N. M., Romano, G. R., Lin, T., Quynh, N., & Irannejad, R. (2022) · eLife · doi:10.7554/elife.75468 · Cited by 43 · see citing works
Reinwald, J., Gass, N., Mallien, A. S., Sartorius, A., Becker, R., Sack, M., Falfán-Melgoza, C., von Hohenberg, C. C., Leo, D., Pfeiffer, N., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01471-4 · Cited by 42 · see citing works
Maseed, H., Reddy, Y. V. M., Devarakonda, S. S., Petnikota, S., Madhavi, G., & Srikanth, V. V. S. S. (2023) · ACS Applied Nano Materials · doi:10.1021/acsanm.3c04018 · Cited by 42 · see citing works
Cell-type diversity in the bed nucleus of the stria terminalis to regulate motivated behaviors
Ortiz-Juza, M. M., Alghorazi, R., & Rodríguez-Romaguera, J. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113401 · Cited by 41 · see citing works
Surface-Enhanced Raman Scattering Nanosensing and Imaging in Neuroscience
Boudries, R., Williams, H., Paquereau--Gaboreau, S., Bashir, S., Jodaylami, M. H., Chisanga, M., Trudeau, L., & Masson, J. (2024) · ACS Nano · doi:10.1021/acsnano.4c05200 · Cited by 40 · see citing works
Electrochemical Properties of Screen-Printed Carbon Nano-Onion Electrodes
Cumba, L. R., Camisasca, A., Giordani, S., & Forster, R. J. (2020) · Molecules · doi:10.3390/molecules25173884 · Cited by 41 · see citing works
Lai, Y., Lu, X., Liao, Y., Ouyang, P., Wang, H., Zhang, X., Huang, G., Qi, S., & Li, Y. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.05.025 · Cited by 40 · see citing works
The dopaminergic system and Alzheimer’s disease
Zhang, Y., Liang, Y., & Gu, Y. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00230 · Cited by 45 · see citing works
- Authors
- Klein, M. O., Battagello, D. S., Cardoso, A. R., Hauser, D. N., Bittencourt, J. C., & Correa, R. G.
- Affiliations
- Universidade de São Paulo (BR)
- Sanford Burnham Prebys Medical Discovery Institute (US)
- Corresponding author
- Bittencourt, Jackson C.
- Correa, Ricardo G.
- ORCID
- Venue
- Cellular and Molecular Neurobiology
- Published
- 2018-11-16
- Volume
- 39
- Issue
- 1
- Pages
- 31-59
- ISSN
- 0272-4340 (ISSN-L)
- 1573-6830
- PMC
- PMC11469830
- OpenAlex
- W2901208536
- Cited by
- 1,073
- References
- 472
- Citations by year
- 2026: 141 · 2025: 174 · 2024: 214 · 2023: 199 · 2022: 148 · 2021: 105 · 2020: 64 · 2019: 27 · 2012: 1
- FWCI
- 6.41
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Cellular and Molecular Neurobiology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- dopamine, dopaminergic signaling, dopamine receptors, G protein-coupled receptors, catecholamine neurotransmitters, neuromodulation, neurodegenerative diseases, Parkinson's disease, schizophrenia, Huntington's disease, attention deficit hyperactivity disorder, addiction, dopaminergic therapy, reward and motivation
- MeSH terms
- Animals, Brain, Dopamine, Humans, Models, Biological, Nervous System Diseases, Signal Transduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review